INTERLEUKIN-2 STIMULATED T LYMPHOCYTE CELL DEATH FOR THE TREATMENT OF AUTOIMMUNE DISEASES, ALLERGIC DISORDERS, AND GRAFT REJECTION - Patent 0705107

(19)

(11)

EP 0 705 107 A1

(12)

(43)	Date of publication:
	10.04.1996 Bulletin 1996/15

(21)	Application number: 93916463.0

(22)	Date of filing: 09.06.1993

(51)

International Patent Classification (IPC):

A61K 38/ 17^{( . )}

A61K 38/ 20^{( . )}

(86)	International application number:
	PCT/US1993/005481

(87)	International publication number:
	WO 1994/028926 (22.12.1994 Gazette 1994/28)

(84)	Designated Contracting States:
	DE ES FR GB IT

(71)	Applicant: THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services
	Bethesda, Maryland 20892 (US)

(72)	Inventor:
	LENARDO, Michael J. Potomac, MD 20854-2453 (US)

(74)	Representative: Hotz, Klaus, Dipl.-El.-Ing./ETH Patentanwalt
	c/o OK pat AG Hinterbergstrasse 36 Postfach 5254 CH-6330 Cham CH-6330 Cham (CH)

(54)	INTERLEUKIN-2 STIMULATED T LYMPHOCYTE CELL DEATH FOR THE TREATMENT OF AUTOIMMUNE DISEASES, ALLERGIC DISORDERS, AND GRAFT REJECTION